Medexus Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 2.81
| MDP Stock | 2.81 0.07 2.43% |
Medexus |
Medexus Pharmaceuticals Target Price Odds to finish over 2.81
The tendency of Medexus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.81 | 90 days | 2.81 | about 60.75 |
Based on a normal probability distribution, the odds of Medexus Pharmaceuticals to move above the current price in 90 days from now is about 60.75 (This Medexus Pharmaceuticals probability density function shows the probability of Medexus Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Medexus Pharmaceuticals has a beta of -0.31. This indicates as returns on the benchmark increase, returns on holding Medexus Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Medexus Pharmaceuticals is likely to outperform the market. Additionally Medexus Pharmaceuticals has an alpha of 0.3409, implying that it can generate a 0.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Medexus Pharmaceuticals Price Density |
| Price |
Predictive Modules for Medexus Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medexus Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Medexus Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Medexus Pharmaceuticals is not an exception. The market had few large corrections towards the Medexus Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medexus Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medexus Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.34 | |
β | Beta against Dow Jones | -0.31 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | 0.05 |
Medexus Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medexus Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medexus Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Medexus Pharmaceuticals had very high historical volatility over the last 90 days | |
| Latest headline from news.google.com: Medexus Pharmaceuticals is a buy, Research Capital says - Cantech Letter |
Medexus Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medexus Stock often depends not only on the future outlook of the current and potential Medexus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medexus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.3 M | |
| Cash And Short Term Investments | 24 M |
Medexus Pharmaceuticals Technical Analysis
Medexus Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Medexus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medexus Pharmaceuticals. In general, you should focus on analyzing Medexus Stock price patterns and their correlations with different microeconomic environments and drivers.
Medexus Pharmaceuticals Predictive Forecast Models
Medexus Pharmaceuticals' time-series forecasting models is one of many Medexus Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medexus Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Medexus Pharmaceuticals
Checking the ongoing alerts about Medexus Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medexus Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Medexus Pharmaceuticals had very high historical volatility over the last 90 days | |
| Latest headline from news.google.com: Medexus Pharmaceuticals is a buy, Research Capital says - Cantech Letter |
Other Information on Investing in Medexus Stock
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.